SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Grönberg Henrik) "

Sökning: WFRF:(Grönberg Henrik)

Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
91.
  •  
92.
  •  
93.
  •  
94.
  • Lindström, Sara, 1979- (författare)
  • Genetic variation and prostate cancer population-based association studies in Sweden
  • 2007
  • Doktorsavhandling (övrigt vetenskapligt)abstract
    • <p>Prostate cancer constitutes the most common malignancy and the most common cause of cancer‐related death in Swedish men. A large body of evidence suggests that inherited genetic variants contribute to both development and progression of prostate cancer. The aim of this thesis is to identify genetic variants that alter prostate cancer risk and progression. All papers included in this thesis are based on a Swedish population‐based case‐control study (CAPS) comprising 2,965 incident prostate cancer cases and 1,823 controls.</p><p>In paper I, we investigated if genetic variants in the E‐cadherin gene altered prostate cancer risk. Seven haplotype tagging SNPs(tagSNPs) were selected and genotyped in CAPS and families with hereditary prostate cancer. We confirmed association of a promoter SNP rs16260 previously reported to increase risk of hereditary prostate cancer (OR: 2.6; 95% CI: 1.6‐4.3) for homozygous ‘A’ carriers.</p><p>In paper II, we assessed 46 polymorphisms earlier reported to be associated with prostate cancer risk. Six polymorphisms in five different genes were replicated. Interestingly, three of these genes were involved in the androgen biosynthesis.</p><p>In paper III, we followed up on the results from paper II by genotyping 23 tagSNPs located in the hormone regulating genes AR, CYP17 and SRD5A2. Multiple SNPs and haplotypes were associated with</p><p>prostate cancer risk, especially in the AR gene. Combining risk alleles from all genes revealed a substantial risk increase for each additional allele carried (OR: 1.12; 95% CI: 1.1‐1.2, P=0.00009).</p><p>In paper IV, we collected information about cause of death for all case patients in CAPS. At time of follow‐up 300 study subjects were deceased from prostate cancer. We assessed AR, CYP17 and SRD5A2 variants for association with lethal prostate cancer and found overall no association. However, one AR promoter SNP was associated with an increased risk of dying from prostate cancer amongst men who received palliative hormonal therapy as primary treatment.</p><p>In paper V, we assessed common genetic variation at the ERG locus for association between prostate cancer risk and survival. ERG is recognized as a protooncogene frequently overexpressed in prostate cancer. A total of 21 tagSNPs in the 5’ region of ERG were genotyped. There was no correlation between ERG SNPs and prostate cancer risk but common genetic variation located approximately 100,000 basepairs upstream of ERG was significantly associated with prostate cancer specific survival.</p><p>In summary, our results suggest that common genetic variation in Ecadherin alters prostate cancer risk in Swedish men with a positive family history of prostate cancer. Moreover, common genetic variation in the androgen‐related genes AR, CYP17 and SRD5A2 affects the risk of developing prostate cancer but is unlikely to alter prostate cancer progression. However, genetic variants in AR may affect hormonal therapy response. Finally, ERG polymorphisms are associated with prostate cancer‐specific death but are not likely to play a role in prostate cancer development.</p>
  •  
95.
  • Lindström, Sara, et al. (författare)
  • Genetic variation in the upstream region of ERG and prostate cancer.
  • 2009
  • Ingår i: Cancer Causes and Control. - 0957-5243 .- 1573-7225. ; 20:7, s. 1173-1180
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>OBJECTIVE: A considerable fraction of prostate cancers harbor a gene fusion between the androgen-regulated TMPRSS2 and ERG, one of the most frequently over-expressed proto-oncogenes in prostate cancer. Here, we investigated if inherited genetic variation upstream of ERG alters prostate cancer risk and survival. METHODS: We genotyped 21 haplotype tagging SNPs (htSNPs) covering 123 kb of 5'UTR DNA including exon 3 of ERG in 2,760 incident prostate cancer cases and 1,647 controls from a population-based Swedish case-control study (CAPS). Individual SNPs and haplotypes were tested for association with prostate cancer risk and survival. RESULTS: One haplotype-'CTCGTATG' located 100 kb upstream of ERG-was associated with lethal prostate cancer (HR, 1.36; 95% CI, 1.2-1.9, p = 0.006). Carriers of the variant 'T' allele of rs2836626 were diagnosed with higher TNM-stage (p = 0.009) and had an increased risk of prostate cancer-specific death (HR = 1.3; 95% CI, 1.1-1.7, p = 0.009). However, this association did not remain statistically significant after adjusting for multiple testing. We found overall no association between ERG variation and prostate cancer risk. CONCLUSIONS: Genetic variation upstream of ERG may alter prostate cancer stage and ultimately prostate cancer-specific death but it is unlikely that it plays a role in prostate cancer development.</p>
  •  
96.
  •  
97.
  •  
98.
  • Lindström, Sara, et al. (författare)
  • Sequence variants in the TLR4 and TLR6-1-10 genes and prostate cancer risk. Results based on pooled analysis from three independent studies.
  • 2010
  • Ingår i: Cancer Epidemiology, Biomarkers and Prevention. - 1055-9965 .- 1538-7755. ; 19:3, s. 873-876
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>BACKGROUND: Genetic variation in two members of the Toll-like receptor family, TLR4 and the gene cluster TLR6-1-10, has been implicated in prostate cancer in several studies but the associated alleles have not been consistent across reports. METHODS: We did a pooled analysis combining genotype data from three case-control studies, Cancer of the Prostate in Sweden, the Health Professionals Follow-up Study, and the Prostate, Lung, Colon and Ovarian Cancer Screening Trial, with data from 3,101 prostate cancer cases and 2,523 controls. We did imputation to obtain dense coverage of the genes and comparable genotype data for all cohorts. In total, 58 single nucleotide polymorphisms in TLR4 and 96 single nucleotide polymorphisms in TLR6-1-10 were genotyped or imputed and analyzed in the entire data set. We did a cohort-specific analysis as well as meta-analysis and pooled analysis. We also evaluated whether the analyses differed by age or disease severity. RESULTS: We observed no overall association between genetic variation at the TLR4 and TLR6-1-10 loci and risk of prostate cancer. CONCLUSIONS: Common germ line genetic variation in TLR4 and TLR6-1-10 did not seem to have a strong association with risk of prostate cancer. IMPACT: This study suggests that earlier associations between prostate cancer risk and TLR4 and TLR6-1-10 sequence variants were chance findings. To definitely assess the causal relationship between TLR sequence variants and prostate cancer risk, very large sample sizes are needed.</p>
  •  
99.
  •  
100.
  • Liu, Wennuan, et al. (författare)
  • Association of a germ-line copy number variation at 2p24.3 and risk for aggressive prostate cancer.
  • 2009
  • Ingår i: Cancer research. - 1538-7445. ; 69:6, s. 2176-9
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>We searched for deletions in the germ-line genome among 498 aggressive prostate cancer cases and 494 controls from a population-based study in Sweden [CAncer of the Prostate in Sweden (CAPS)] using Affymetrix SNP arrays. By comparing allele intensities of approximately 500,000 SNP probes across the genome, a germ-line deletion at 2p24.3 was observed to be significantly more common in cases (12.63%) than in controls (8.28%); P = 0.028. To confirm the association, we genotyped this germ-line copy number variation (CNV) in additional subjects from CAPS and from Johns Hopkins Hospital (JHH). Overall, among 4,314 cases and 2,176 controls examined, the CNV was significantly associated with prostate cancer risk [odds ratio (OR), 1.25; 95% confidence interval (95% CI), 1.06-1.48; P = 0.009]. More importantly, the association was stronger for aggressive prostate cancer (OR, 1.31; 95% CI, 1.08-1.58; P = 0.006) than for nonaggressive prostate cancer (OR, 1.19; 95% CI, 0.98-1.45; P = 0.08). The biological effect of this germ-line CNV is unknown because no known gene resides in the deletion. Results from this study represent the first novel germ-line CNV that was identified from a genome-wide search and was significantly, but moderately, associated with prostate cancer risk. Additional confirmation of this association and functional studies are warranted.</p>
  •  
Skapa referenser, mejla, bekava och länka
Åtkomst
fritt online (26)
Typ av publikation
tidskriftsartikel (163)
doktorsavhandling (8)
annan publikation (7)
konferensbidrag (6)
rapport (1)
bokkapitel (1)
visa fler...
visa färre...
Typ av innehåll
refereegranskat (167)
övrigt vetenskapligt (24)
populärvet., debatt m.m. (1)
Författare/redaktör
Grönberg, Henrik (152)
Wiklund, Fredrik (80)
Xu, Jianfeng (49)
Adami, Hans Olov (48)
Stattin, Pär, (47)
Bälter, Katarina (32)
visa fler...
Isaacs, William B (32)
Zheng, S Lilly (25)
Sun, Jielin (24)
Gronberg, H, (21)
Emanuelsson, Monica (19)
Wiinikka, Henrik, (19)
Isaacs, Sarah D (17)
Chang, Bao-Li (17)
Wiley, Kathleen E (16)
Johansson, Jan-Erik (15)
Adolfsson, Jan (15)
Duggan, David (15)
Hsu, Fang-Chi (15)
Liu, Wennuan (15)
Walsh, Patrick C (14)
Lindström, Sara, (13)
Carpten, John D (12)
Hedelin, Maria (12)
Hall, Per (11)
Thorleifsson, Gudmar (11)
Hofman, Albert (10)
Montgomery, Grant W. (10)
Mangino, Massimo (10)
Jackson, Anne U. (10)
Yang, Jian (10)
Heard-Costa, Nancy L ... (10)
Luan, Jian'an (10)
Feitosa, Mary F. (10)
Esko, Tonu (10)
Prokopenko, Inga (10)
Hayward, Caroline (10)
Jacobs, Kevin B. (10)
Monda, Keri L. (10)
Steinthorsdottir, Va ... (10)
Campbell, Harry (10)
Hicks, Andrew A. (10)
McArdle, Wendy L. (10)
Collins, Francis S. (10)
Hengstenberg, Christ ... (10)
Erdmann, Jeanette (10)
Mägi, Reedik (10)
Grönberg, C., (10)
Li, Ge, (10)
Meyers, Deborah A (10)
visa färre...
Lärosäte
Umeå universitet (101)
Karolinska Institutet (26)
Göteborgs universitet (18)
Lunds universitet (17)
Uppsala universitet (16)
Luleå tekniska universitet (8)
visa fler...
Örebro universitet (8)
RISE (8)
Högskolan i Gävle (3)
Stockholms universitet (2)
Högskolan i Jönköping (2)
Högskolan Kristianstad (1)
Högskolan Väst (1)
Linköpings universitet (1)
Chalmers tekniska högskola (1)
Blekinge Tekniska Högskola (1)
visa färre...
Språk
Engelska (175)
Svenska (3)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (100)
Teknik (14)
Naturvetenskap (5)
Lantbruksvetenskap (1)

År

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy